Regulatory eosinophils in inflammation and metabolic disorders

Immune Network

Volumn 17, Issue 1, 2017, Pages 41-47

  Yang, Bo Gie ^a   Seoh, Ju Yong ^b   Jang, Myoung Ho ^c  

^a Yonsei University College of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Anti inflammation; Eosinophils; IgA; IL 1R antagonist; IL 4; Th17 cells

Indexed keywords

EOSINOPHIL; HOMEOSTASIS; HUMAN; INFLAMMATION; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 85020061800     PISSN: 15982629     EISSN: 20926685     Source Type: Journal    
DOI: 10.4110/in.2017.17.1.41     Document Type: Review

References (40)

1. Rothenberg, M. E., and S.P. Hogan. 2006. The Eosinophil. Annu. Rev. Immunol. 24: 147-174.
2. Garcia, N. V., E. Umemoto, Y. Sito, M. Yamasaki, E. Hata, T. Matozaki, M. Murakami, Y.-J. Jung, S.-Y. Woo, J.-Y. Seoh, M. H. Jang, K. Aozasa and M. Miyasaka. 2011. SIRPa/CD172a regulates eosinophil homeostasis. J. Immunol. 187: 2268-2277.
3. Carlens, J., B. Wahl, M. Ballmaier, S. Bulfone-Paus, R. Förster and O. Pabst. 2009. Common g-chain-dependent signal confer selevtive survival of eosinophils in the murine small intestine. J. Immunol. 183: 5600-5607.
4. Mishra, A., S. P. Hogan, J. J. Lee, P. S. Foster, M. E. Rothenberg. 1999. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J. Clin. Invest. 103: 1719-1727.
5. Dent, L. A., M. Strath, A. L. Mellor, and C. J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172: 1425-1431.
6. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, lung damage in a mouse asthma model. J. Exp. Med. 183: 195-201.
7. Nussbaum, J. C., S. J. V. Dyken, J. V. Moltke, L. E. Cheng, A. Mohapatra, A. B. Molofsky, E. E. Thornton, M. F. Krummel, A. Chawla, H.-E. Liang, and R. M. Locksley. 2013. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502: 245-248.
8. Yu, C., A. B. Cantor, H. Yang, C. Browne, R. A. Wells, Y. Fujiwara, and S. H Orkin. 2002. Targeted deletion of a highaffinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med. 195: 1387-1395.
9. Lee, J. J., D. Dimina, M. P. Macias, S. I. Ochkur, M. P. Mcgarry, K. R. O’Neill, C. Protheroe, R. Pero, T. Nguyen, S. A. Cormier, E. Lenkiewicz, D. Colbert, L. Rinaldi, S. J. Ackerman, C. G. Irvin, and N. A. Lee. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305: 1773-1776.
10. Chu, V. T., A. Beller, S. Rausch, J. Strandmark, M. Zänker, O. Arbach, A. Kruglov, and C. Berek. 2014. Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. Immunity 40: 582-593.
11. Sugawara, R., E.-J. Lee, M. S. Jang, E.-J. Jeun, C.-P. Hong, J.-H. Kim, A. Park, C. H. Yun, S.-W. Hong, Y.-M. Kim, J.-Y. Seoh, Y. Jung, C. D. Surh, M. Miyasaka, B.-G. Yang, and M. H. Jang. 2016. Small intestinal eosinophils regulate Th17 cells by producing Il-1 receptor antagonist. J. Exp. Med. 213: 555-567.
12. Wu, D., A. B. Molofsky, H.-E. Liang, R. R. Ricardo-Gonzalez, H. A. Jouihan, J. K. Bando, A. Chawla, and R. M. Locksley. 2011. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332: 243-247.
13. Qiu, Y. K. D. Nguyen, J. I. Odegaard, X. Cui, X. Tian, R. M. Locksley, R. D. Palmiter, and A. Chawla. 2014. Eosinophils and type 2 cyotkine signaling in macrophages orchestrate development of functional beige fat. Cell 157: 1292-1308.
14. Slims, J. E., and D. E. Smith. 2010. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10: 89-102.
15. Casini-Raggi, V., L. Kam, Y. J. Chong, C. Fiocchi, T. T. Pizarro, and F. Cominelli. 1995. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J. Immunol. 154: 2434-2440.
16. Nakae, S., S. Saijo, R. Horai, K. Sudo, S. Mori, and Y. Kwakura. 2003. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. U.S.A. 100: 5986-5990.
17. Koenders, M. I., I. Devesa, R. J. Marijnissen, S. Abdollahi-Roodsaz, A. M. Boots, B. Walgreen, F. E. di Padova, M. J. Nicklin, L. A. Joosten, and W. B. van den Berg. 2008. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis Rheum. 58: 3461-3470.
18. Shaw, M., N. Kamada, Y.-G. Kim, and G. Núñez. 2012. Microbiota-induced IL-1b, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J. Exp. Med. 209: 251-258.
19. Chu, D. K., R. Jimenez-Saiz, C. P. Verschoor, T. D. Walker, S. Goncharova, A. Llop-Guevara, P. Shen, M. E. Gordon, N. G. Barra, J. D. Bassett, J. Kong, R. Fattouh, K. D. McCoy, D. M. Bowdish, J. S. Erjefält, O. Pabst, A. A. Humbles, R. Kolbeck, S.Waserman, and M. Jordana. 2014. Indigenous enteric eosinophils contraol DCs to initiate a primary Th2 immune response in vivo. J. Exp. Med. 211: 1657-1672.
20. El-Behi, M., B. Ciric, H. Dai, Y. Yan, M. Cullimore, F. Safavi, G.-X. Zhang, B.N. Dittel, and A. Rostami. 2011. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12: 568-575.
21. Griseri, T., I. C. Arnold, C. Pearson, T. Krausgruber, C. Schiering, F. Franchini, J. Schulthess, B. S. McKenzie, P. R. Crocker, and F. Powrie. 2015. Granulocyte macrophage colony-stimulating factor-activated eosinophils promote interleukin-23 drive chronic colitis. Immunity 43: 187-199.
22. Fagarasan, S., S. Kawamoto, O. Kanagawa, and K. Suzuki. 2010. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu. Rev. Immunol. 28: 243-273.
23. Cazac, B. B., and J. Roes. 2000. TGF-b receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13: 443-451.
24. Dullaers, M., D. Li, Y. Xue, L. Ni, I. Gayet, R. Morita, H. Ueno, K. A. Palucka, J. Banchereau, and S. Oh. 2009. A T celldependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity 30: 120-129.
25. Cassese, G., S. Arce, A. E. Hauser, K. Lehnert, B. Moewes, M. Mostarac, G. Muehlinghaus, M. Szyska, A. Radbruch, and R. A. Manz. 2003. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171: 1684-1690.
26. Chu, V. T., A. Fröhlich, G. Steinhauser, T. Scheel, T. Roch, S. Fillatreau, J. J. Lee, M. Löhning, and C. Berek. 2011. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat. Immunol. 12: 151-159.
27. Jung, Y., T. Wen, M. K. Mingler, J. M. Caldwell, Y. H. Wang, D. D. Chaplin, E. H. Lee, M. H. Jang, S. Y. Woo, J. Y. Seoh, M. Miyasaka, and M. E. Rothenberg. 2015. IL-1b in eosinophilmediated small intestinal homeostasis and IgA production. Mucosal Immunol. 8: 930-942.
28. Yousefi, S., J. A. Gold, N. Andina, J. J. Lee, A. M. Kelly, E. Kozlowski, I. Schmid, A. Straumann, J. Reichenbach, G. J. Gleich, and H.-U. Simon. 2008. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med. 14: 949-953.
29. Donath, M. Y., and S. E. Shoelson. 2011. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11: 98-107.
30. Lackey, D. E., and J. M. Olefsky. 2016. Regulation of metabolism by the innate immune system. Nat. Rev. Endocrinol. 12: 15-28.
31. Molofsky, A. B., J. C. Nussbaum, H.-E. Liang, S. J. V. Dyken, L. E. Cheng, A. Mohapatra, A. Chawla, and R. M. Lacksley. 2013. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210: 535-549.
32. Brestoff, J. R., B. S. Kim, S. A. Saenz, R. R. Stine, L. A. Monticelli, G. F. Sonnenberg, J. J. Thome, D. L. Farber, K. Lutfy, P. Seale, and D. Artis. 2015. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519: 242-246.
33. Lee, S. D., and P. Tontonoz. 2014. Eosinophils in fat: pink is the new brown. Cell 157: 1249-1250.
34. Harms, M., and P. Seale. 2013. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19: 1252-1263.
35. Bartelt, A., and J. Heeren. 2014. Adipose tissue browning and metabolic health. Nat. Rev. Endocrinol. 10: 24-36.
36. Rao, R. R., J. Z. Long, J. P. White, K. J. Svensson, J. Lou, I. Lokurkar, M. P. Jedrychowski, J. L. Ruas, C. D. Wrann, J. C. Lo, D. M. Camera, J. Lachery, S. Gygi, J. Seehra, J. A. Hawley, and B. M. Spiegelman. 2014. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 157: 1279-1291.
37. Winer, D. A., H. Luck, S. Tsai, and S. Winer. 2016. The intestinal immune system in obesity and insulin resistance. Cell Metab. 23: 413-426.
38. Turnbaugh, P. J., R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
39. Suárez-Zamorano, N., S. Fabbiano, C. Chevalier, O. Stojanović, D. J. Colin, A. Stevanović, C. Veyrat-Durebex, V. Tarallo, D. Rigo, S. Germain, M. Ilievska, X. Montet, Y. Seimbille, S. Hapfelmeier, and M. Trajkovski. 2015. Microbiota depletion promotes browning of white adipose tissue and reduces obesity. Nat. Med. 21: 1497-1501.
40. Lee, H. S., M. S. Jang, J. H. Kim, C. P. Hong, E. J. Lee, E. J. Jeun, C. Kim, E. K. Kim, K. S. Ahn, B. G. Yang, K. S. Ahn, Y. P. Jang, K. S. Ahn, Y. M. Kim, and M. H. Jang. 2013. Ulmus davidiana var. japonica Nakai upregulates eosinophils and suppresses Th1 and Th17 cells in the small intestine. PLoS One 8: e76716.